Strength
.375 g/1
Manufacturer
AvPAKNDC
50268057715
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214242On Market Since
1/16/2023
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 150 times since Aug 16, 2023, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4979 per EA |
|---|---|
| All-time high | $1.0513 (Sep 13, 2023) |
| All-time low | $0.4196 (Feb 18, 2026) |
| 52-week high | $0.4979 |
| 52-week low | $0.4196 |
| Median price | $0.4979 |
| Average price | $0.5792 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 150 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by AvPAK, is $0.4979 per EA (NDC 50268057715), effective Jun 24, 2026.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 37.2%. It has been tracked across 150 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Aug 16, 2023, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $1.0513 (Sep 13, 2023), with a median of $0.4979 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE ER 0.375 GRAM CAP, but none are currently priced below it.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 50268057715) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification